2022
DOI: 10.34172/apb.2023.022
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Evaluation of Lipofectamine and Dendrimer for Transfection of Short RNA Into Human T47D and MCF-10A Cell Lines

Abstract: Purpose: Non-viral transfection approaches are extensively used in cancer therapy. The future of cancer therapy lies on targeted and efficient drug/gene delivery. The aim of this study was to determine the transfection yields of two commercially available transfection reagents (i.e. Lipofectamine 2000, as a cationic lipid and PAMAM G5, as a cationic dendrimer) in two breast cell lines: cancerous cells (T47D) and non-cancerous ones (MCF-10A). Methods: We investigated the efficiencies of Lipofectamine 2000 and P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 34 publications
1
1
0
Order By: Relevance
“…Comparing this figure with silibinin, a principal active constituent of the SM, is encouraging. Our findings accord with previous studies, which suggested that silibinin and SM nanoformulation could be potent inducers of BAX and inhibitors of the BCL2 gene expression. , BAX / BCL2 ratio was increased after the SW480 cell treatment with the SM–tin­(IV) complex. Proapoptotic BAX to antiapoptotic BCL2 is a crucial hallmark of cell susceptibility to apoptosis. It seems that the alterations above in the expression of BAX and BCL2 go hand in hand to sensitize cells to death.…”
Section: Discussionsupporting
confidence: 92%
“…Comparing this figure with silibinin, a principal active constituent of the SM, is encouraging. Our findings accord with previous studies, which suggested that silibinin and SM nanoformulation could be potent inducers of BAX and inhibitors of the BCL2 gene expression. , BAX / BCL2 ratio was increased after the SW480 cell treatment with the SM–tin­(IV) complex. Proapoptotic BAX to antiapoptotic BCL2 is a crucial hallmark of cell susceptibility to apoptosis. It seems that the alterations above in the expression of BAX and BCL2 go hand in hand to sensitize cells to death.…”
Section: Discussionsupporting
confidence: 92%
“…Many studies have reported the inhibition of proliferation and cell cycle progression by silibinin in numerous cancers (6,7). It has also been reported that silibinin alone can induce apoptosis and cell cycle arrest in the paclitaxel-resistant ovarian carcinoma cell line and sensitize these cells to paclitaxel (8)(9)(10)(11)(12)(13). Silibinin is well-tolerated by the body and has proven less toxic than other anticancer therapeutics (7).…”
Section: Introductionmentioning
confidence: 99%